The protective effects of compatibility of Aconiti Lateralis Radix Praeparata and Zingiberis Rhizoma on rats with heart failure by enhancing mitochondrial biogenesis …
X Lu, L Zhang, P Li, J Wang, R Li, Y Huang… - Biomedicine & …, 2017 - Elsevier
Abstract Aconiti Lateralis Radix Praeparata (“Fuzi” in Chinese) in combination with
Zingiberis Rhizoma (“Ganjiang” in Chinese) is commonly applied for the treatment of heart
failure for thousands of years in China. However, its therapeutic mechanism is still poorly
defined. This study aimed to investigate whether the compatibility of Fuzi and Ganjiang can
protect rats with acute heart failure by enhancing mitochondrial biogenesis via Sirt1/PGC-1α
signaling pathway. Hemodynamic parameters, including heart rate and left ventricular …
Zingiberis Rhizoma (“Ganjiang” in Chinese) is commonly applied for the treatment of heart
failure for thousands of years in China. However, its therapeutic mechanism is still poorly
defined. This study aimed to investigate whether the compatibility of Fuzi and Ganjiang can
protect rats with acute heart failure by enhancing mitochondrial biogenesis via Sirt1/PGC-1α
signaling pathway. Hemodynamic parameters, including heart rate and left ventricular …
The protective effects of compatibility of Aconiti Lateralis Radix Praeparata and Zingiberis Rhizoma on rats with heart failure by enhancing mitochondrial biogenesis …
LXH Lu XiaoHua, ZL Zhang Lu, LPY Li PengYan… - 2017 - cabidigitallibrary.org
Abstract Aconiti Lateralis Radix Praeparata (" Fuzi" in Chinese) in combination with
Zingiberis Rhizoma (" Ganjiang" in Chinese) is commonly applied for the treatment of heart
failure for thousands of years in China. However, its therapeutic mechanism is still poorly
defined. This study aimed to investigate whether the compatibility of Fuzi and Ganjiang can
protect rats with acute heart failure by enhancing mitochondrial biogenesis via Sirt1/PGC-1α
signaling pathway. Hemodynamic parameters, including heart rate and left ventricular …
Zingiberis Rhizoma (" Ganjiang" in Chinese) is commonly applied for the treatment of heart
failure for thousands of years in China. However, its therapeutic mechanism is still poorly
defined. This study aimed to investigate whether the compatibility of Fuzi and Ganjiang can
protect rats with acute heart failure by enhancing mitochondrial biogenesis via Sirt1/PGC-1α
signaling pathway. Hemodynamic parameters, including heart rate and left ventricular …
以上显示的是最相近的搜索结果。 查看全部搜索结果